25
Jun 2019
Pioneering ‘living drug’ gives hope to terminal blood cancer patients
A new pioneering treatment has been offered to lymphoma patients which genetically re-programmes their immune system to fight cancer. The new CAR-T therapy, is a ‘living drug- which is personalised to each patient by using their body’s own cells. The process involves with removal of white blood cells, also known as T-cells, from the patient’s…
